0001415889-21-001930.txt : 20210407
0001415889-21-001930.hdr.sgml : 20210407
20210407160524
ACCESSION NUMBER: 0001415889-21-001930
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210405
FILED AS OF DATE: 20210407
DATE AS OF CHANGE: 20210407
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kerr Douglas
CENTRAL INDEX KEY: 0001814189
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39319
FILM NUMBER: 21812128
MAIL ADDRESS:
STREET 1: C/O GENERATION BIO CO.
STREET 2: 301 BINNEY STREET, SUITE 401
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Generation Bio Co.
CENTRAL INDEX KEY: 0001733294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 814301281
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 857-529-5908
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
form4-04072021_010433.xml
X0306
4
2021-04-05
0001733294
Generation Bio Co.
GBIO
0001814189
Kerr Douglas
C/O GENERATION BIO CO., 301 BINNEY ST
CAMBRIDGE
MA
02142
false
true
false
false
CHIEF MEDICAL OFFICER
Common Stock
2021-04-05
4
M
0
14072
5.16
A
340630
D
Common Stock
2021-04-05
4
S
0
10751
29.91
D
329879
D
Common Stock
2021-04-05
4
S
0
3321
30.68
D
326558
D
Stock Option (right to buy)
5.16
2021-04-05
4
M
0
14072
0
D
2030-03-04
Common Stock
14072
42217
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.34 to $30.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.36 to $31.17, inclusive.
The option to purchase 56,289 shares of common stock was granted on March 5, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on March 5, 2021 and the remaining shares vesting in equal quarterly installments thereafter.
/s/ Jennifer Elliott, Attorney-in-Fact
2021-04-07